Stemcentrx

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Abdera Therapeutics

This biopharmaceutical company develops antibody-based radiopharmaceuticals to treat patients with small cell lung cancer and other solid tumours.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Angiex

This company develops antibody-drug conjugates for clinicians and pharmaceutical partners to treat solid cancers and vascular diseases.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

CTRL Therapeutics

This company develops cell therapies for solid tumours and microfluidic platforms to identify rare tumour-reactive lymphocytes for cancer patients.